Seer, Inc.
NASDAQ: SEER0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Omid C. Farokhzad
- Employees
- 134
- Headquarters
- Redwood City, United States
- IPO year
- 2020
- Market cap
- $92.9M
- Website
- https://seer.bio
Loading SEER…
Loading profile data…Frequently asked questions about SEER
What does Seer, Inc. (SEER) do?
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This compreh...
Where does SEER trade?
Seer, Inc. (SEER) trades on the NASDAQ Global Select.
What sector is SEER in?
Seer, Inc. (SEER) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Seer, Inc.?
Omid C. Farokhzad is the chief executive officer of Seer, Inc. (SEER).
Where is Seer, Inc. headquartered?
Seer, Inc. is headquartered in United States.
Does SEER pay a dividend?
Seer, Inc. (SEER) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SEER go public?
Seer, Inc. (SEER) completed its initial public offering in 2020.